Response to the Letter to the Editor Entitled “Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy”

By afschroeder • August 2, 2026

Giri K, Glassock RJ, Fervenza FC. Response to the Letter to the Editor Entitled "Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy". Kidney Int Rep. 2026 Jun 6;11(9):106658. doi: 10.1016/j.ekir.2026.106658. PMID: 42541134; PMCID: PMC13427534.

Tags: Emeritus, Harbor UCLA, Nephrology, Publications

Opportunistic Chest CT Paraspinal Muscle Biomarkers to Predict Longitudinal Thoracic Vertebral Bone Mineral Density Loss: Results from MESA

Hathaway QA, Ghotbi E, Pan T, Momtazmanesh S, Klein JG, Allison M, Barbosa EJM Jr, Barr RG, Bluemke DA, Lima JAC, Post W, Tison GH,[...]

Building Families-Implementing Balanced Sexual and Reproductive Health: A Joint IFFS and ISA Scientific Statement

Liu PY, Mocanu E, Giudice L, Horton M, Nigdelis MP, Perheentupa A, Sansone A, Corona G, Gianaroli L, Goulis DG. Building Families-Implementing Balanced Sexual and[...]

Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma

Paniker AG, Marshalek JP, Chao E, Yashar D, Tomassetti S. Management Patterns and Outcomes for Relapsed or Refractory Hodgkin Lymphoma. J Hematol. 2026 Aug 31;15(4):188-197.[...]